The author presents a provocative modeling-based demonstration of an innovative alternative to the traditional one-size-fits-all maximally tolerated dose concept. The concept of individualized pharmacokinetic-based precision dosing is intuitively appealing and the analyses presented herein support potential utility from the development and application of such methods.